Salomon & Ludwin
CRL icon

Salomon & Ludwin’s Charles River Laboratories CRL Stock Holding History

Salomon & Ludwin’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$18K Hold
61
– – ﹤0.01% 1013
2026
Q2 		$14K Hold
61
– – ﹤0.01% 1412
2026
Q1 		$10.6K Hold
61
– – ﹤0.01% 1495
2025
Q4 		$12.7K Hold
61
– – ﹤0.01% 1275
2025
Q3 		$10.8K Buy
+61
New +$9.7K ﹤0.01% 1247

Other funds holding CRL

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Cooke & Bieler
Cooke & Bieler Philadelphia, Pennsylvania $6.36B AUM 0.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Van Berkom & Associates
Van Berkom & Associates Montreal, Quebec, Canada $2.81B AUM 6.02% 1-Year Est. Return
Boston Trust Walden
Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

Salomon & Ludwin's CRL Position: Q3 2026 in Review

Salomon & Ludwin held its Charles River Laboratories (CRL) position steady in Q3 2026 at 61 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #1013.

Salomon & Ludwin first reported a position in CRL in Q3 2025 and has held it in 5 quarters since. 285 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

  • Salomon & Ludwin held 61 shares of Charles River Laboratories worth $18K as of Q3 2026.
  • Salomon & Ludwin left its Charles River Laboratories share count unchanged in Q3 2026.
  • Charles River Laboratories made up ﹤0.01% of Salomon & Ludwin's portfolio in Q3 2026, its #1013 holding.
  • Salomon & Ludwin first reported a position in Charles River Laboratories in Q3 2025 and has held it in 5 quarters since.
  • 285 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on Salomon & Ludwin's 13F filing for Q3 2026, filed 29 Oct 2026.